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It has been reported that the crossveinless-c locus of Drosophila melanogaster
corresponds the RhoGAP88C gene. This determination was based on three criteria:
proximity in genetic map position, complementation tests, and similarity of phenotype
between RhoGAP88C RNAi constructs and the phenotype of hypomorphic cv-c' mutant
homozygotes, both of which eliminate posterior crossveins (Denholm et al. 2005). There
are several genes that map to this region of chromosome 3, including both RhoGAP88C,
and a poorly annotated PDZ-domain containing gene corresponding to Expressed
Sequence Tag (EST) Clot 13975 (approximately 60 kb upstream from the RhoGAP88C
transcriptional start). A P-element insertion P[PZ]l(3)06951 is located immediately
adjacent to an EST Clot 13975, but the homozygous lethal phenotype of the insertion
appears to be unrelated to this EST. The data presented by Denholm et al. (2005)
showing that 1(3)06951 fails to complement cv-c1 is relatively weak; only about 35% of
1(3)06951/cv-c' heterozygotes have a broken crossvein phenotype. This is in spite of the
fact that 1(3)06951 is homozygous lethal, and cv-c1 homozygotes have a completely
penetrant broken/missing crossvein phenotype. I have mobilized 1(3)06951 and
recovered lethal insertion mutants 500 bp away from the original insertion that
complement 1(3)06951 and fail to complement cv-c1 with a completely penetrant
posterior crossveinless phenotype. I hypothesize based, on our data and that of Denholm
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et al. (2005), that P[PZ]l(3)06951 and RhoGAP88C are allelic with one another and
distinct from the cv-c locus. I have used Real-Time PCR to show that mutations that fail
to complement cv-c and mutations that fail to complement RhoGAP88C result in lower
levels of both RhoGAP and Clot 13975 transcripts. This suggests that the mutations in
the region may be affecting transcription levels of multiple mRNAs and may be causing
some of the difficulty in assigning mutations to specific genetic loci.
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INTRODUCTION
Defects of the posterior crossvein in Drosophila have been extensively studied.
In 1923, Timofeeff-Ressovsky discovered a gene that caused defects in the posterior
crossvein of Drosophila funebris (Milkman, 1964). Since this discovery there have been
many works published on the formation of crossveins in Drosophila. Roughly a dozen
spontaneous mutations mapping to all of the major Drosophila chromosomes have been
recovered that produce broken crossvein or crossveinless phenotypes (Milkman, 1964;
Marcus, 2001). Most of these mutations remain uncharacterized at the molecular level
and represent an excellent opportunity to dissect the developmental genetics of a simple
morphological structure.
Introduction to wing development. Insect wings are only two cell layers thick
(Marcus, 2001) and the veins in the wings of Drosophila are made up of tubes of thick
chitin derived from the remains of the densely packed cells in the wing surfaces (Mohler
and Swedberg, 1964). Crossveins form primarily in one wing surface or the other but can
pass from one surface of the wing to the other. In insects, crossveins serve as a
supporting structure of the wing to aid in flight (Marcus, 2001) and, in some species of
moths, crossveins in the wings serve as the organizational center of eyespots (Monterio et
al. 2006). Crossvein development occurs in three stages. In the first stage, the position
and number of the crossveins are determined along the proximal-distal axis and may
involve signaling processes that include Cdc-42 (Agnes et al. 1999), Jun-N-Terminal
Kinase (JNK), and as Hsp90 (Rutherford and Lindquist, 1998). Cdc-42 is a G-protein
that is involved in the regulation of the cell cycle and JNK is involved in several
processes, such as apoptosis, cell differentiation and proliferation, and other cell cycle
processes (Oltmanns et al. 2003). The Cdc-42 locus was originally discovered in yeast
during cell division and has been shown to encode a member of the rho family of small
GTPases (Ziman et al. 1991). In Drosophila melanogaster, Cdc-42 is required for many
actin-dependent cellular processes as well as important developmental processes, such as
cellular proliferation, differentiation, morphogenetic movements and cell signaling events
(Genova et al. 2000). Martin-Bianco et al. (1998) and Agnes et al. (1999) have suggested
that the Cdc-42 locus may promote the production of the ligand decapentaplegic {dpp).
Hsp90 is a heat shock protein that acts as a chaperone for cells undergoing stress during
increase heat and has roles in signaling, protein folding and tumor suppression
(Rutherford and Lindquist, 1998).
In the second stage of the crossvein formation there is cell-cell signaling between
the dorsal and ventral wing surfaces (Garcia-Bellido, 1977) to initiate the crossvein
formation, which involves the transforming growth factor-(3 (TGF-(3) signaling pathway
(Conley et al. 2000), which includes the ligand dpp. The TGF-|3 pathway is involved in
several cellular processes, including cell growth, differentiation and apoptosis. The third
stage in the development involves localized signaling through the Egfr-MapK pathway
and Notch signaling in the ventral surface of the wing to refine/condense the vein
structure (Sturtevant and Bier, 1995; Yu et al. 1996; de Celis et al. 1997; Huppert et al.
1997; Marcus, 2001).
Developmental studies. An effective way to study the development of a
particular phenotype is to study mutants that alter that phenotype. In a famous series of
experiments, Waddington (1953) discovered that crossvein formation was sensitive to
high temperature, paving the way for more developmental studies into the formation of
crossveins.
Genetic variation or the effects of specific environmental stimuli at critical stages
of development can produce similar phenotypes. From these observations, it was then
suggested that the selection for the ability to adaptively modify a specific character would
ultimately lead to a genetic mechanism to produce the induced character (Bateman,
1957). How is this possible? In 1896, Baldwin, Osborn and Lloyd Morgan proposed that
the selection for an inducible phenotype in a population allowed the population to survive
until the time when the specific mutation could occur to produce that phenotype
genetically (Gause, 1947). Waddington (1953) suggested an alternative: that by selecting
for genotypes capable of producing environmentally induced phenotypes, one also often
simultaneously selects for genotypes that produce those phenotypes constitutively (that
is, regardless of environmental conditions). This process Waddington had described was
given the term "genetic assimilation of an acquired character" (Bateman, 1957).
There have been several studies of mutations that have reduced or completely
removed the crossveins. Some of these mutations include crossveinless (cv),
crossveinless-2 (cv-2) and crossveinless-c (cv-c). The cv gene has been characterized at
the molecular level and has been shown to be a paralog of twisted gastrulation (tsg-2)
(Ross et al. 2001; Marcus, 2003), which is required to specify the dorsal-most structures
in embryos and which also inhibits two TGF-(3 homologs in Drosophila,
Decapentaplegic (Dpp) and Glass bottom boat (Gbb). Previous studies have shown that
crossveinless/tsg-2 is required on the dorsal wing surface to induce cells capable of
producing crossveins on the ventral wing surface (Garcia-Bellido, 1977).
Crossvein development. In wild-type Drosophila strains, during pupal
development a central vesicle forms in the wing discs at 21 hours around where the
posterior crossveins (PCV) form. The lumen of the central vesicle is what forms the
PCV. In crossveinless-like mutants, when the pupa is 22-24 hours old the longitudinal
veins (LVs) are present, but the lumen is eliminated from the central vesicle when the
two layers of the wing come together. When this occurs, the developing PCV space is
destroyed, and cellular processes continue as in other non-vein areas (Mohler and
Swedberg, 1964).
The crossveinless-2 gene product appears to promote the TGF-(3 signal through
the ligands dpp/gbb. The ligand dpp and the TGF-(3 signaling pathway is believed to play
a roll in vein formation in the wings of Drosophila. In the wing discs of the developing
flies, dpp is expressed between the LVs 3 and 4 (Figure 1) and is involved in setting up
the longitudinal axis for the wings. The dpp signals seem to be mediated by a type I
receptor, Thickveins (Tkv) since cells that lack this gene product fail to form veins.
Other factors have been shown to interact with TGF-|3 -like signals to cause a reduction
in the formation of veins. For example, the Sog gene encodes for a Chordin-like
molecule that has been shown to inhibit TGF-(3 -like signals by binding to ligands to
prevent them from activating the receptors (Figure 2). Others, such as tolkin mutants
(which is related to the Tolloid proteases) block the formation of CV and the tips of the
LVs (Figure 1). These phenotypes that have been observed are similar to the
crossveinless class of mutations seen in Drosophila (Conley et al. 2000).
Introduction to crossveinless-c1. The crossveinless-c1 (cv-c1) mutant in
Drosophila melanogaster was produced by a spontaneous mutation that is not associated
with a visible chromosomal lesion (Lindsley and Grell, 1944) and has been identified by
Denholm et al. (2005) as being a mutation in RhoGAP, which also interacts with Cdc-42.
I suspect that there is another gene that may carry the cv-c1 lesion instead of RhoGAP as
suggested by Denholm et al. (2005).
MATERIALS AND METHODS
Fly strains
Drosophila strains used in experiments: Oregon-R; P[PZ]l(3)06951/TM6 Sb; Sb1
A2-3/TM6; DF(3R)Exel6267/TM6B, Tb1 and cv-c1 were obtained from the Drosophila
Stock Center, at the University of Indiana; cv-c2, st e/TM6 Hu; cv-c3, st e/TM6 Hu; cv-c4,
st e/TM6 Hu; cv-c5, st e/TM6 Hu; cv-c6, st e/TM6 Hu; cv-c7, st e/TM6 Hu; cv-c8, st e/TM6
Hu; cv-cM62/TM3, Sb; CV-CC52VTM3, Sb; cv-cni/TM3, Sb were obtained from Dr. Barry
Denholm, Dr. Rob Roy and Dr. Helen Skaer. All stocks were grown on instant
Drosophila medium (Carolina Biological) at 25°C.
Mutagenesis Screen
P-element transposon mutagenesis. A transposon is what is commonly known as
a jumping gene because of its ability to move from one location to another in the genome
(McClintock, 1950). Transposon mutagenesis was used because of its ability to select for
a precise excision of the initial P-element transposon followed by a reinsertion into the
cv-c locus. This method is useful since the sequence of the transposon is known and can
be used as a starting point for sequencing the surrounding DNA. This is often referred to
as a sequence tagged mutation. To generate new mutations in cv-c, the P-element stock
used was P[PZ]l(3)06951/TM6 Sb which was crossed to Sb1 A2-3/TM6 which carries a
source of transposase, an enzyme that can bind to double-stranded DNA to allow it to be
incorporated into the genomic DNA (Robertson et al. 1988; Cooley et al. 1988). The
male progeny from this cross with the genotype P[PZJl(3)06951/Sb' A2-3 was crossed
back to virgin females of the parental transposon stock. Males were selected for this
cross because there is no recombination in male Drosophila. The males that have
undergone the precise excision and become viable over the original P-element were
crossed to female virgins of cv-c' sbd2. Individual males with the genotype
P[PZ]l(3)06951/cv-c' sbd2 were crossed to virgin females of genotype TM3/TM6. The
male and virgin female progeny from the same vial were crossed to each other in order to
establish the mutant line (Figure 3).
Complementation Tests
cv-c1 flies were crossed to P[PZ]l(3)06951/TM6 Sb and to P[PZ]37.6.1/TM6;
adult Fl flies were harvested and stored them in 90% ethanol. Individual wings were
removed with forceps and mounted on slides with Euparol mountant. Slides were
photographed using an Olympus BH-2 microscope with a 2 Megapixel JVC Digital
Camera KY-F75U with Synchroscopy Auto-Montage software.
Inverse PCR and Sequencing
Once the mutant stocks were created, inverse PCR and sequencing of the flanking
regions were performed. Genomic DNA was prepared from adult flies carrying the P-
element insertion using the Qiagen DNeasy kit. The genomic DNA was digested with
Sau3A, Mspl, and HinPI restriction enzymes and then circularized with T4 DNA ligase.
The sequences flanking the P-element inserts were amplified by inverse PCR using the
protocol from the Berkeley Drosophila Genome Project, 2003. The PCR primers used
match the sequences of the P-element. Forward primers Plac4 or Pry2 and reverse
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primers Placl or Pryl were used (Table 1). Plac4 and Placl primers were paired together
and Pry2 and Pryl primers were paired together. Successful Plac4 and Placl
amplifications were sequenced (10 \il reactions) using primers Splac2 and Spl and
successful Pry2 and Pryl amplifications were sequenced using the primers Sp3 and
Spepl (Table 1) (Berkley Drosophila Genome Project, 2003). The dye-set used was the
ABI BigDye® Terminator v3.1 Sequencing Juice (Applied Biosystems, Inc. Fosters City,
CA). For each sequencing reaction, an isopropanol precipitation was used to clean up the
reaction for use on an ABI 3130 DNA analyzer (Applied Biosystems, Inc. Fosters City,
CA). The P-element flanking sequences, obtained by trimming off the transposon from
the inverse PCR sequence, were compared to the Drosophila genomic scaffold sequence
by a BLAST search in FlyBase (Adams et al. 2000), to determine the locations of the
insertion sites.
RNA Preparation
mRNA was prepared from third instar larvae using a Qiagen RNeasy kit. Before
Real-Time PCR could be performed, reverse transcription PCR (RT-PCR) needed to be
performed. Protocol used for RT-PCR was Protoscript® First Strand cDNA Synthesis
Kit by New England BioLabs®, Inc. A four-step dilution (concentrations: 400 uL, 80
uL, 40 uL, and 4 uL) of each sample with two replicates of Real-Time PCR for each of
the four primer sets was performed on cDNA samples for Oregon-R (wild-type); cv-
c'/cv-c'; P[PZ]l(3)06951/TM6Sb\ DF(3R)Exel6267/TM6B, Tb' (a deficiency that
removes the entire region); the point mutants created by Denholm et al. (2005); and the
new transposon mutants that I generated, using primers for Clot 13975 and RhoGAP
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(Table 2) as well as the housekeeping gene, elongation factor 1-a (EFla). The EFla
gene has been shown to be a useful reference gene for the accurate normalization in real-
time PCR studies (Infante et al. 2008). The Clot 13975 and RhoGAP primers were
designed using VectorNTI with the sequences known for both regions. Primers were
then tested using a standard PCR protocol and gel electrophoresis. Two primers sets for
the Clot 13975 and only one primer set for the RhoGAP sequences worked.
The conditions for Clot 13975 and RhoGAP PCR amplifications were 95°C for 5
minutes; 35 cycles at 95°C for 1 minute, 51°C (Clot 13975) or 56°C (RhoGAP) for 1
minute, 72 C for 1 minute; 72 C for 5 minutes and 4 C hold. The PCR conditions for the
EFla primers are 95 C for 5 minutes; 40 cycles at 95 C for 1 minute, 50 C for 1 minute,
72°C for 1 minute 30 seconds; 72°C for 10 minutes and 4°C hold. For the Clot 1 and
RhoGAP primers, 0.5 uL Mg2+ had to be added to the Real-Time PCR reaction. For the
Clot 2 primer, 1.0 (J.L Mg2+ had to be added to the Real-Time PCR reaction. The dye used
for visualization was 25 uL of iQ™ SYBR® Green Supermix at a concentration of 2X
(Bio-Rad Laboratories, 2000) for use with the Bio-Rad iCycler Thermal Cycler.
Functional Tests of RhoGAP and Clot 13975
To try to rescue the cv-c phenotype, UAS constructs carrying full length RhoGAP
and Clot 13975 transcripts are used. Flies carrying UAS-RhoGAP88C construct on
Chromosome III was obtained from Dr. Barry Denholm's lab. A genetic crossing
scheme was devised to bring cv-c' and RhoGAP88C into the same Drosophila stock.
Males with homozygous genotype cv-c' sbd2 were crossed to females apxa/CyO;
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l(3)/TM3Sb. Males from this cross with the genotype +/CyO; cv-c' sbd2/TM3Sb or
+/CyO; cv-c1 sbd2/l(3) were then crossed to virgin females from the same cross with
genotype +/apxa; cv-c' sbd2/TM3Sb. Males and virgin females from this cross with the
genotype apxa/Cy0; cv-c' sbcf/cv-c1 sbd2 were used to make a stock (Figure 4).
To obtain the full-length transcript of the Clot 13975 gene, cDNA of Oregon-R
flies were used. PCR was performed using primers for ClotFl and cDNA cloning primer
(Tables 2 and 3) with the same PCR conditions described in previous section for Clot
13975 primers. The amplified products from these PCR reactions were then used as the
DNA template for a series of nested PCR reactions using the primers ClotF2 and 3'
RACE PCR primers (Tables 2 and 3). These PCR products were then used for TOPO®
TA Cloning® Kit by Invitrogen to clone the PCR products into a vector. JM109
competent cells were transformed using the newly cloned vector using Heat-shock
transformation. The cloned vector was added to the competent cells and placed on ice for
five minutes then transferred to 42 C for 30 seconds to heat-shock the competent cells
and placed them back on ice. The newly transformed competent cells were then grown
on LB plates with X-gal; colonies were picked off and grown in liquid cultures (Seidman
et al. 1997). Plasmid preps were made using UltraClean™ 6 Minute Mini Plasmid Prep
Kit by MoBio Laboratories, Inc. The new plasmid preps were then sequenced using Ml 3
forward and reverse primers (Table 3). The sequencing protocol was the same as
described above in the section Inverse PCR and Sequencing.
RESULTS
Mutagenesis Screen
After crossing the transposon stock P[PZ]l(3)06951/TM6 Sb to the stock Sb1 A2-
3/TM6 that carries transposase, I was able to recover three lethal transposon insertions
that complemented P[PZ]l(3)06951 and produced a posterior crossveinless phenotype
over cv-c1. Sequencing of inverse PCR products showed that all three lethal insertions
share the same new insertion site, which was not in the RhoGAP coding sequence (Figure
5). Performing the complementation test in the crossing scheme for mutagenesis insured
that the transposon was in cv-c. When I performed a complementation test, I was able to
recover 3 mutations, P[PZ]5.2.6, P[PZ]7.2.4, and P[PZ]37.6.1, that complemented
1(3)06951, which Denholm et al (2005) suggested was a mutation in RhoGAP, but failed
to complement cv-c1. This suggests that 1(3)06951 and cv-c are different genes.
Complementation Tests
The wing phenotypes observed in P[PZ]l(3)069551/cv-c1 Fl heterozygotes were
somewhat different from those previously described by Denholm et al. (2005) for the
same genotype. Denholm et al. (2005) reported the complete absence of posterior
crossveins in this genotype, while my observations of the same genotype suggest that
roughly 35% of individuals have broken posterior crossveins, but these crossveins were
never completely absent (Figure 6). P[PZ]5.2.6/cv-c', P[PZ]7.2.4/cv-c' and
P[PZ]37.6.1/cv-c' Fl heterozygotes show a complete loss of posterior crossveins,
indicating that there is no complementation between the new insertion mutants and cv-c1.
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Inverse PCR
Sequencing of the inverse PCR products for the flanking sequences surrounding
P[PZ]5.2.6/TM6, P[PZ]7.2.4/TM6 and P[PZ]3 7.6.1/TM6 insertions reveals that all three
newly recovered transposon insertions are in the same location and immediately adjacent
to a DNA sequence that apparently encodes a PDZ domain. PDZ domains help to anchor
transmembrane proteins to the cytoskeleton and hold cell-cell signaling complexes
together (Doyle et al. 1996). This PDZ domain-containing sequence appears in multiple
Drosophila EST libraries, is apparently expressed, and is sometimes referred to as EST
Clot 13975. Clot 13975 is approximately 60 kb upstream of the transcriptional start site
of RhoGAP88C and may be an alternative gene product involved in producing
crossveinless phenotypes.
Real-Time
I performed a four-step dilution of cDNA from wild-type and mutant RhoGAP
and Clot 13975 samples with two replicates of each sample for real-time PCR analysis.
The data gathered was normalized with respect to EFlcc PCR amplifications prepared
from the same cDNA samples (Infante et al. 2008). After normalization, the data shows
that all mutants, both Denholm et al (2005) point mutants (assigned to RhoGAP) and the
transposon insertion mutants created in our lab (assigned to Clot 13975), have lower
mRNA transcripts for both Clot 13975 and RhoGAP. This information suggests that
there is coregulation of the two genes (Tables 4, 5 and 6; Figure 7).
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Functional tests ofRhoGAP and Clot 13975
The crosses to put UAS-RhoGAP into a cv-c1 background are ongoing as well as
efforts to complete the sequencing of the Clot 13975 cDNA. Once the sequencing of the
cDNA for the Clot 13975 is complete, the cDNA will then be cloned into the pUAST
construct obtained from Andrea Brand's lab and injected into apxa/Cy0; cv-c''sba^/cv-
c'sbd2 flies. These transformed flies and those from the crosses shown in Figure 4 will
be crossed to heat-shocked (hs)-Gal4 driver lines to finish the functional tests.
DISCUSSION
Is the cv-c mutation located in RhoGAPl Previous reports stated that
P[PZ]l(3)06951/cv-c' lacked posterior crossveins (Denholm et al. 2005). When I
repeated the crosses necessary to produce this genotype, it occasionally (-35%) produced
broken crossveins but the crossveins were never completely absent (Figure 6). The new
insertion mutants that I generated, when placed over cv-c1 (e.g. P[PZ]37.6.1/cv-c1) show
a completely absent posterior crossvein indicating that there is no complementation
between the two alleles. These phenotypes suggest that cv-c1 may not be a mutation in
RhoGAP as previously reported (Denholm et al. 2005) but may be a mutation in another
gene. The lesion that produced the original cv-c1 mutation has never been characterized
at the molecular level, and so the transcript that it actually affects is still unknown. By
performing Real-time PCR I was hoping to determine which transcript was being reduced
in expression by the various mutations and found that both transcripts were being reduced
in most of the mutations. This data suggests that there is coregulation of RhoGAP and
Clot 13975 since both transcripts are being reduced by our transposon mutants and the
point mutants created by Denholm et al (2005).
In eukaryotes, transcriptional regulation usually operates at the level of individual
genes and the transcription of any one gene is dependent on a promoter sequence located
upstream of the transcriptional start site. The activity of these promoters can be modified
by the binding of transcription factors to specific DNA sequences known as regulatory
modules (Harding et al. 1989). These can either increase or decrease the amount of
16
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transcription for a specific gene, depending on the activities of the bound transcription
factors. In Drosophila, it was found that over 20% of genes that are subject to regulation
are clustered into coregulated groups made up of 10-30 genes (Spellman and Rubin,
2002). In addition, roughly 29% of unannotated transcription fragments, with
characteristics similar to Clot 13975 are coregulated with one or more known gene
(Manak et al. 2006).
The microarray experiments performed by Spellman and Rubin (2002) do not
show the mechanism by which the observed similarities of expression of adjacent genes.
Spellman and Rubin (2002) believe their findings are consistent with the regulation being
at the level of chromatin structure. These researchers came to this conclusion for two
reasons; first, the regions they observed with similarities in expression were very large,
containing about 15 genes, each with their own core promoter; and second, one or two
genes in a group show high levels of differential expression. Spellman and Rubin (2002)
explained how the chromatin could effect coregulation of genes. They suggested that in a
region with multiple genes, the chromatin was then opened to allow for one of the genes
to be transcribed, this could then increase the accessibility of promoter and enhancers for
the other genes in the region. This could cause for an increase in transcription of multiple
genes (Spellman and Rubin, 2002). Both Denholm et al. (2005) and I made mutations
that are unlikely to have disrupted the chromatin structure of a large section of
chromosome. Many of the mutants made by Denholm et al. (2005) are point mutations
and the mutants made in my lab have an inserted transposon sequence of about 3 kb that
18
likely would not have grossly disrupted chromatin structure. Yet, these mutations result
in down-regulation of both transcripts.
Manak et al. (2006) suggest two additional hypotheses for why an unannotated
transcribed sequence fragment might be coregulated with a known gene. One hypothesis
is that they are independent transcripts that have similar intensities and time of expression
with known genes, perhaps because they are affected by shared enhancer elements.
Alternatively, a second hypothesis proposed by Manak et al. (2006) is that the
unannotated transcript is coordinately regulated with the known gene because it
represents a previously unidentified portion of that gene. My results show that the two
transposon insertion locations {P[PZ]l(3)06951 and the three mutants that I created, all of
which are inserts at the same site) are homozygous lethal, but complement each other.
This suggests that there are two genes, however, this is not a fool-proof explanation.
Intragenic complementation is when two mutations in the same gene complement each
other, however, this type of complementation is unusual. There may be other evidence to
support an intragenic complementation hypothesis, however, by the map positions of the
RhoGAP and Clot 13975 transcripts. RhoGAP and the EST containing the PDZ domain
for Clot 13975 are shown to be oriented in the same direction on the same strand of
DNA, this increases the likelihood that these are the same transcript. Although, when
ESTs are captured, they are usually captured at the 3' end of a transcript. The 3' end of
the Clot 13975 is at the 5' end of the RhoGAP transcript.
19
I therefore conclude that it is highly likely that there are two separate transcripts,
one for rhoGAP and one for cv-c1. The complementation test data support this
contention, but the fact that mutations in this region have a tendency to affect the
expression of both transcripts, makes it more difficult to assign phenotypes to particular
coding sequences. With the functional tests that I am performing currently, I hope to be
able to definitively answer the question of where this cv-c1 mutation occurs.
20
LV3
LV4
ACV
PCV
LV5
Figure 1. Wild-type wing showing the longitudinal veins (LV), Anterior crossvein
(ACV), and Posterior crossvein (PCV).
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Figure 2. When cv-2 is activated, this causes the release of the ligands Glass bottom
boat (gbb) and Decapentaplegic (dpp). These ligands will then bind to Sax receptors, to
promote the formation of crossveins. Sog gene products will bind and sequester ligands
gbb and dpp to prevent them from activating receptors. To!kin (tol) protease can also
bind and cleave Sog, inhibiting its activity and facilitating signaling of gbb and dpp. cv-2
can be mutated to prevent the release of gbb or dpp.
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Figure 3. Transposon mutagenesis screen for insertions that complement
P[PZ]l(3)06951, but fail to complement cv-c'. I recovered 3 such insertions
P[PZ]37.6.1, P[PZ]7.2.4, P[PZ]5.2.6 each of which are homozygous lethal, viable over
P[PZ]l(3)06951, and produce a crossveinless phenotype over cv-c'.
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Figure 4. Crossing scheme in preparation for functional tests of RhoGAP and Clot
13975.
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Figure 5. Inverse PCR of transposon insertions indicates that the new mutations are
immediately adjacent to EST sequences (in green) that compose Clotl3975 and are
outside of the translated region of rhoGAP (translated region: 10217402-10221479).
Clotl3975 consists of a fragment of apparent coding sequence that contains a PDZ
domain. I am trying to characterize the rest of the transcript. I suspect that this transcript
represents the gene product of cv-c'. The lesion that causes the cv-c' mutation remains
undiscovered. P-element transposons indicated by the blue arrows. In FlyBase, the
RhoGAP gene is called cv-c.
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A cv-c'/Oregon R ^- B cv-c'/cv-c'
'/P[PZ]l(3)06951
Figure 6. Adult wing phenotypes of (A) Wild-type and (B) cv-c1 homozygotes and
heterozygotes. (C) cv-c1 /P[PZ]l(3)06951 produces a partially penetrant broken posterior
crossvein phenotype in 35% of the progeny with (D) 65% of the progeny have wild-type
crossveins. (E) It produces a completely penetrant missing posterior crossvein phenotype
over P[PZ]3 7.6.1 and similar insertion mutants from the screen.
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Figure 7. Plot of log-transformed real-time PCR data obtained
using primers for portions of Clotl3975 and rhoGAP, standardized
by comparison with the constitutively expressed transcription factor
EF1-alpha. These plots show Oregon-R wild-type levels of gene
expression in blue. All of the transposon insertion alleles recovered
in our screen show a reduction in both levels of Clot 13975
expression and rhoGAP expression. This is shown by a positive
vertical displacement of the Ct values in the plots above. Similarly,
all of the alleles in rhoGAP recovered by Denholm et al. (2005)
show a reduction in the expression of both gene products and a
positive vertical displacement of the Ct values.
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Table 1. Inverse PCR primer sequences
Primer Sequence
Plac4 ACT GTG CGT TAG GTC CTG TTC ATT GTT
Pry2 CCT GCC GAC GGG ACC ACC TTA TGT TAT T
Placl CAC CCA AGG CTC TGC TCC CAC AAT
Pryl CCT TAG CAT GTC CGT GGG GTT TGA AT
Splac2 GAA TTC ACT GGC CGT CGT TTT ACA A
Spl ACA CAA CCT TTC CTC TCA ACA A
Sp3 GAG TAC GCA AAG CTT TAA CTA TGT
Spepl GAC ACT CAG AAT ACT ATT C
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Table 2. PCR primers for Clot 13975, RhoGAP, and E F l a (Monteiro and Pierce, 2001)
Primers Sequence
ClotFl AGT TGG GTT TCC ACC TCG AC
ClotRl CCG CGC TAC ATT TTC GTA TT
ClotF2 TTA TTG GCA GTT CTC AGG TT
ClotR2 TTT AAT GGA GAG TGC CTT TT
RhoGAPFl GCC GTG CAC GGT TGT CGA TTC T
RhoGAPRl TCT GCA ATC TTG CGT TCG CG
ef44(f) GCY GAR CGY GAR CGT GGT ATY AC
ef51(r) CAT GTT GTC GCC GTG CCA AC
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Table 3. Cloning primer sequences used to obtain the Clot 13975 sequence.
Primers Sequence
3' RACE PCR GGC CAC GCG TCG ACT AGT AC
cDNA Cloning Primer GGC CAC GCG TCG ACT AGT ACT TTT TTT
TTT TTT TTT TV
M l 3 forward (-20) GTA AAA CGA CGG CCA GT
Ml3 forward (-41) CGC CAG GGT TTT CCC AGT CAC
M13 reverse (-27) CAG GAA ACA GCT ATG AC
Ml 3 reverse (-48) AGC GGA TAA CAA TTT CAC ACA GG
Table 4. Normalized Clot 1 Larvae of Ct values from Real-Time PCR. The numbers in this table show the mean values and (standard
deviation) of the Ct values for gene expression for the replicates for each sample. The Ct value shows the fractional cycle at which the
fluorescence intensity for the sample equals the threshold fluorescence. These values are inversely related to the abundance of the
specific transcript (Clot 13975 or RhoGAP) in the sample. When these values are converted to linear form, the changes in gene
expression can then be estimated (Infante et al. 2008).
Clot 1
Larvae
Dilution
1
0.2
0.1
0.01
1
0.2
0.1
0.01
Oregon-R
24.0(0.7)
26.3(0.1)
27.9(0.3)
30.9(0.9)
cv-c8
25.5(8.9)
32.0(2.6)
32.3(4.8)
35.1(9.3)
1(3)06951
25.0(1.1)
27.0(0.4)
28.4(0.9)
32.8(0.5)
cv-cM62
23.5(1.2)
28.3(1.7)
28.9(1.3)
33.0(0.6)
Df(3R)Exel62
26.3(1.6)
30.7(3.7)
31.7(2.7)
35.0(0.9)
cv-cC524
23.8(0.7)
27.3(2.8)
26.6(0.4)
30.7(1.4)
cv-c1
25.0(0.5)
28.9(3.6)
30.8(1.2)
32.9(2.2)
cv-cJ17
24.1(0.8)
26.5(0.8)
28.9(1.7)
32.4(4.2)
cv-c2
25.8(2.4)
29.0(2.1)
29.3(0.2)
32.1(1.2)
5.3.6
24.4(0.2)
26.9(1.9)
29.3(0.4)
31.7(0.6)
cv-c3
24.5(1.6)
27.6(1.2)
29.2(1.0)
31.9(1.0)
7.2.4
25.8(2.8)
29.4(1.1)
29.7(0.9)
31.7(0.8)
cv-c4
24.7(0.1)
27.4(2.5)
29.0(1.1)
30.4(4.0)
37.6.1
25.5(1.4)
27.9(1.0)
28.8(0.3)
31.5(0.1)
cv-c5
23.6(1.3)
25.4(1.1)
27.8(1.8)
31.7(5.9)
cv-c6
24.1(3
27.9(0
27.7(2
31.2(5
•1)
-8)
•5)
•6)
cv-c7
25.4(3.1)
28.4(2.8)
30.2(0.8)
26.9(2.4)
o
Table 5. Normalized Clot 2 Larvae of Ct values from Real-Time PCR. The numbers in this table show the mean values and (standard
deviation) of the Ct values for gene expression for the replicates for each sample. The Ct value shows the fractional cycle at which the
fluorescence intensity for the sample equals the thieshold fluorescence. These values are inversely related to the abundance of the
specific transcript (Clot 13975 or RhoGAP) in the sample. When these values are converted to linear form, the changes in gene
expression can then be estimated (Infante et al. 2008).
Clot 2
Larvae Dilution
1
0.2
0.1
0.01
1
0.2
0.1
0.01
Oregon-R
24.5(0.1)
26.1(0.1)
27.9(0.8)
30.2(0.6)
cv-c8
25.9(10.6)
29.5(20.9)
27.4(19.4)
27.3(19.3)
1(3)06951
24.7(0)
25.8(1.1)
27.7(19.6)
31.1(0.3)
cv-cM62
24.4(1.7)
28.7(1.8)
29.4(1.3)
33.4(0.4)
Df(3R)Exel62
25.4(1.8)
29.7(2.7)
31.7(2.9)
35.0(2.9)
cv-cC524
24.4(1.7)
28.7(1.8)
29.4(1.3)
33.4(0.4)
cv-c1
24.6(1.6)
28.7(1.8)
30.0(1.3)
32.0(1.3)
cv-cJ17
24.8(1.3)
27.6(1.9)
26.9(0.9)
30.8(2.0)
cv-c2
25.2(2.7)
28.1(0.5)
28.3(1.3)
32.1(1.0)
5.3.6
25.7(0.2)
28.4(1.5)
30.0(0.1)
32.5(0.5)
cv-c3
25.0(0.6)
29.2(0.6)
30.0(2.0)
32.6(2.1)
7.2.4
26.2(0.8)
31.1(2.1)
31.0(1.3)
33.0(0.4)
cv-c4
25.1(0.1)
28.9(3.4)
28.7(2.0)
31.7(4.1)
37.6.1
27.3(1.2)
29.4(1.0)
30.0(1.3)
33.0(0.8)
cv-c5
25.4(0.6)
27.0(0.7)
28.1(0.8)
32.3(3.3)
cv-c6
23.8(2.8)
29.3(1.0)
29.0(1.6)
32.6(6.0)
cv-c7
25.2(0.6)
30.0(2.1)
30.7(0.7)
31.8(5.8)
Table 6. Normalized RhoGAP Larvae of Ct values from Real-Time PCR. The numbers in this table show the mean values and
(standard deviation) of the Ct values for gene expression for the replicates for each sample. The Ct value shows the fractional cycle at
which the fluorescence intensity for the sample equals the threshold fluorescence. These values are inversely related to the abundance
of the specific transcript (Clot 13975 or RhoGAP) in the sample. When these values are converted to linear form, the changes in gene
expression can then be estimated (Infante et al. 2008).
RhoGAP
Larvae
Dilution
1
0.2
0.1
0.01
1
0.2
0.1
0.01
Oregon-R
23.5(1.3)
26.8(0.6)
28.0(0.3)
31.0(1.5)
cv-c7
23.8(0.5)
29.5(3.7)
30.4(0.8)
31.5(8.2)
1(3)06951
24.2(1.6)
26.8(1.3)
28.0(2.1)
31.2(1.9)
cv-c8
24.4(8.6)
32.5(4.1)
29.0(20.5)
33.4(8.0)
Df(3R)Exel62
25.0(2.3)
29.2(5.3)
31.7(1.8)
33.3(0.2)
cv-cM62
24.0(1.2)
28.9(2.6)
29.2(1.1)
32.2(1.4)
cv-c1
23.7(1.0)
29.1(3.5)
30.1(0.3)
31.7(0.1)
cv-cC524
23.9(0.1)
27.2(2.5)
26.7(0.8)
30.8(2.5)
cv-c2
25.1(3.0)
28.2(1.7)
29.4(0.7)
32.3(0.9)
cv-cJ17
23.7(0.8)
26.7(1.8)
29.7(2.6)
31.7(4.0)
cv-c3
24.6(1.1)
29.0(2.1)
29.3(1.2)
31.4(0.1)
5.3.6
24.3(0.4)
27.1(2.1)
30.2(0.6)
32.2(0.6)
cv-c4
24.4(0.8)
27.5(3.4)
29.7(2.9)
30.8(5.9)
7.2.4
25.4(1.1)
30.7(2.5)
30.7(0.8)
33.3(1.1)
cv-c5
24.5(1.3)
27.1(1.7)
27.9(3.9)
31.9(7.0)
37.6.1
26.2(1.6)
29.0(2.1)
30.1(1.5)
32.5(0.4)
cv-c6
23.7(2.9)
28.7(2.3)
28.8(1.2)
31.8(6.0)
to
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